—In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity. A study identified 12 significant radiomic features, with four ...

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis develop. Using advanced methodology, scientists in Sweden were able to reveal at ...

Using advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The new results are presented in the journal Cell by researchers ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

Myelocortical multiple sclerosis (MCMS) is a new subtype of multiple sclerosis (MS). It’s the first kind of MS known to cause nerve cell loss without damaging the myelin in your cerebral white matter.

MS is characterized by lesions in the brain and the spinal cord. "We wanted to understand which cells are part of the lesions and their dynamics over time," says Petra Kukanja, co-first author in the ...